On the stump, many of the candidates are railing against skyrocketing drug costs. They promise at campaign rallies at the top of their lungs to “Bring down the cost of drugs.” This blog, however, claims that it’s not only about costly drugs. It’s the whole system that is rigged and has high costs baked into … Continue reading It’s Not Just About Costly Drugs – It’s Testing, Too
The next time you hit a pothole in the road, blame your local health insurance or hospital CEO. Because your hard-earned healthcare premiums and tax dollars are literally going straight into their bonuses at the expense of infrastructure repair. Exorbitant national health spending produces what economists call opportunity costs. Our healthcare spending takes away not just … Continue reading Healthcare Hits A Pothole – And How to Fix It
The Journal of the AMA (JAMA) on March 21 released the most comprehensive study to date on U.S. healthcare spending. It confirms that Americans are spending too much, and getting too little. But it also gives us some new insights on what’s driving up costs. The study has been widely reported in mainstream media – … Continue reading New Data from AMA Journal Rekindles Calls for Healthcare Reform
Noted surgeon and social-medical commentator Atul Gawande MD hosted a video roundtable in 2014 entitled “Avoiding Low-Value Care.” His panel seemingly challenged the idea that low-value care can be avoided, which is the crux of the cost-benefit approach to healthcare reform. But on closer look Dr. Gawande and panel may actually, in fact, be validating … Continue reading Doctors Critique Oregon-Style Cost-Benefit Approach to Healthcare Reform . . . But Not So Fast!
This is a posting of my reply to British health economist Dr. Buchanan's Comment of February 17, 2018. The original posts are: Medicines's future? The health economics of population-wide genomic screening (October 26, 2017) Cost-Effectiveness: From Genes to Healthcare System Reform (December 17, 2017) 2 thoughts on “Cost-Effectiveness: From Genes to Healthcare System Reform” (Reply, February … Continue reading Genes, Cost-Effectiveness and Healthcare Reform – Dialog with Dr. Buchanan